Literature DB >> 25809161

Influenza infection induces host DNA damage and dynamic DNA damage responses during tissue regeneration.

Na Li1, Marcus Parrish, Tze Khee Chan, Lu Yin, Prashant Rai, Yamada Yoshiyuki, Nona Abolhassani, Kong Bing Tan, Orsolya Kiraly, Vincent T K Chow, Bevin P Engelward.   

Abstract

Influenza viruses account for significant morbidity worldwide. Inflammatory responses, including excessive generation of reactive oxygen and nitrogen species (RONS), mediate lung injury in severe influenza infections. However, the molecular basis of inflammation-induced lung damage is not fully understood. Here, we studied influenza H1N1 infected cells in vitro, as well as H1N1 infected mice, and we monitored molecular and cellular responses over the course of 2 weeks in vivo. We show that influenza induces DNA damage to both, when cells are directly exposed to virus in vitro (measured using the comet assay) and also when cells are exposed to virus in vivo (estimated via γH2AX foci). We show that DNA damage, as well as responses to DNA damage persist in vivo until long after virus has been cleared, at times when there are inflammation associated RONS (measured by xanthine oxidase activity and oxidative products). The frequency of lung epithelial and immune cells with increased γH2AX foci is elevated in vivo, especially for dividing cells (Ki-67-positive) exposed to oxidative stress during tissue regeneration. Additionally, we observed a significant increase in apoptotic cells as well as increased levels of DNA double strand break (DSB) repair proteins Ku70, Ku86 and Rad51 during the regenerative phase. In conclusion, results show that influenza induces DNA damage both in vitro and in vivo, and that DNA damage responses are activated, raising the possibility that DNA repair capacity may be a determining factor for tissue recovery and disease outcome.

Entities:  

Mesh:

Year:  2015        PMID: 25809161      PMCID: PMC4802977          DOI: 10.1007/s00018-015-1879-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  118 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study.

Authors:  Ronald C McGarry; Lech Papiez; Mark Williams; Tia Whitford; Robert D Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-22       Impact factor: 7.038

3.  Dose escalation for non-small cell lung cancer using conformal radiation therapy.

Authors:  J M Robertson; R K Ten Haken; M B Hazuka; A T Turrisi; M K Martel; A T Pu; J F Littles; F J Martinez; I R Francis; L E Quint; A S Lichter
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-15       Impact factor: 7.038

4.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.

Authors:  Frank J Lagerwaard; Cornelis J A Haasbeek; Egbert F Smit; Ben J Slotman; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

5.  V(D)J recombinase activity in primary and secondary murine lymphoid organs: assessment by a PCR assay with extrachromosomal plasmids.

Authors:  M Abe; K Hayashida; K Takayama; H Shiku
Journal:  Int Immunol       Date:  1991-10       Impact factor: 4.823

6.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients.

Authors:  H Blomgren; I Lax; I Näslund; R Svanström
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

7.  Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer.

Authors:  Branislav Jeremic; Johannes Classen; Michael Bamberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

8.  Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels.

Authors:  József Lövey; Bíborka Bereczky; Réka Gilly; István Kenessey; Erzsébet Rásó; Erika Simon; Judit Dobos; Agnes Vágó; Miklós Kásler; Balázs Döme; József Tímár; József Tóvári
Journal:  Strahlenther Onkol       Date:  2008-01       Impact factor: 3.621

Review 9.  The comet assay for DNA damage and repair: principles, applications, and limitations.

Authors:  Andrew R Collins
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.860

10.  An optimized method for detecting gamma-H2AX in blood cells reveals a significant interindividual variation in the gamma-H2AX response among humans.

Authors:  Ismail Hassan Ismail; Tabasum Imran Wadhra; Ola Hammarsten
Journal:  Nucleic Acids Res       Date:  2007-02-06       Impact factor: 16.971

View more
  28 in total

1.  Epigenetic and Transcriptomic Regulation of Lung Repair during Recovery from Influenza Infection.

Authors:  Derek A Pociask; Keven M Robinson; Kong Chen; Kevin J McHugh; Michelle E Clay; Grace T Huang; Panayiotis V Benos; Yvonne M W Janssen-Heininger; Jay K Kolls; Vikas Anathy; John F Alcorn
Journal:  Am J Pathol       Date:  2017-02-10       Impact factor: 4.307

Review 2.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

3.  Network perturbation analysis of gene transcriptional profiles reveals protein targets and mechanism of action of drugs and influenza A viral infection.

Authors:  Heeju Noh; Jason E Shoemaker; Rudiyanto Gunawan
Journal:  Nucleic Acids Res       Date:  2018-04-06       Impact factor: 16.971

Review 4.  Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis.

Authors:  Qing Bi; Ji-Yue Wu; Xue-Meng Qiu; Jian-Dong Zhang; Ze-Jia Sun; Wei Wang
Journal:  J Immunol Res       Date:  2022-06-13       Impact factor: 4.493

5.  Ataxia telangiectasia mutated is required for efficient proximal airway epithelial cell regeneration following influenza A virus infection.

Authors:  Rachel Warren; Andrew M Dylag; Molly Behan; William Domm; Min Yee; Margot Mayer-Pröschel; Luis Martinez-Sobrido; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-02-23       Impact factor: 6.011

6.  Zika Virus Infection Induces DNA Damage Response in Human Neural Progenitors That Enhances Viral Replication.

Authors:  Christy Hammack; Sarah C Ogden; Joseph C Madden; Angelica Medina; Chongchong Xu; Ernest Phillips; Yuna Son; Allaura Cone; Serena Giovinazzi; Ruth A Didier; David M Gilbert; Hongjun Song; Guoli Ming; Zhexing Wen; Margo A Brinton; Akash Gunjan; Hengli Tang
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 7.  Applications of CometChip for Environmental Health Studies.

Authors:  Christy Chao; Bevin P Engelward
Journal:  Chem Res Toxicol       Date:  2020-06-10       Impact factor: 3.739

Review 8.  Inflammation-induced DNA damage, mutations and cancer.

Authors:  Jennifer Kay; Elina Thadhani; Leona Samson; Bevin Engelward
Journal:  DNA Repair (Amst)       Date:  2019-07-25

Review 9.  Lessons from the host defences of bats, a unique viral reservoir.

Authors:  Aaron T Irving; Matae Ahn; Geraldine Goh; Danielle E Anderson; Lin-Fa Wang
Journal:  Nature       Date:  2021-01-20       Impact factor: 49.962

10.  Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest.

Authors:  Prashant Rai; Fang He; Jimmy Kwang; Bevin P Engelward; Vincent T K Chow
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.